Progression and Prognostic Indicators of Bronchial Disease in Children with Sickle Cell Disease
Beiträge zur Klinik der Tuberkulose und spezifischen Tuberkulose-Forschung - Tập 192 - Trang 385-393 - 2014
Tóm tắt
The
pulmonary complications of sickle cell disease (SCD) are a leading cause of morbidity and mortality (MacLean et al. Am J Respir Crit Care Med 178:1055–1059, 2008; Klings et al. Am J Respir Crit Care Med 173:1264–1269, 2006; National Heart, Lung, and Blood Institute, 2009). Despite this recognition, predictive markers of lung dysfunction progression remain elusive (Klings et al. Am J Respir Crit Care Med 173:1264–1269, 2006; Platt et al. N Engl J Med 330:1639–1644, 1994; Caboot et al. Curr Opin Pediatr 20:279–287, 2008; Field et al. Am J Hematol 83:574–576, 2008; Shirlo et al. Peadiatr Respir Review 12:78–82, 2011). This study was designed describe the longitudinal progression and identify specific markers that influence bronchial disease in SCD. A retrospective, chart review of 89 patients with SCD was conducted. All patients underwent spirometry in conjunction with body plethysmography as part of routine care. Eleven lung function variables were assessed, five of which were selected to establish patterns of normal, obstructive, restrictive, or mixed obstructive-restrictive physiology (Klings et al. Am J Respir Crit Care Med 173:1264–1269, 2006; Field et al. Am J Hematol 83:574–576, 2008). In the unadjusted model, forced expiratory volume in one second (FEV1)% of predicted trended downward with age, while total lung capacity (TLC)% of predicted showed a bimodal distribution and carbon monoxide diffusion capacity corrected for hemoglobin (DLCOcor)% of predicted remained stable. Adjusting for acute chest syndrome (ACS) episodes, medication status, and growth velocity (GV), the final model demonstrated that the downward trend between FEV1% of predicted with age was further influenced by the latter two factors. Initial decline in FEV1% of predicted is associated with worsening pulmonary dysfunction over time. Independent of ACS episodes, the factors most influential on the progression of FEV1% predicted include the introduction of medications as well as the promotion of adequate prepubertal growth. Efforts to ensure normal prepubertal GV and treatment with bronchodilators, such as short-acting beta2 agonists and inhaled corticosteroids (ICS), should be considered at an early age to delay progression of pulmonary dysfunction.
Tài liệu tham khảo
MacLean JE, Atenafu E, Kirby-Allen M, MacLusky I, Stephens D, Grasemann H, Subbarao P (2008) Longitudinal decline in lung volume in a population of children with sickle cell disease. Am J Respir Crit Care Med 178:1055–1059
Klings E, Wyszynski DF, Nolan VG, Steinberg MH (2006) Abnormal pulmonary function in adults with sickle cell anemia. Am J Respir Crit Care Med 173:1264–1269
National Heart, Lung, and Blood Institute (2009) About sickle cell disease. Retrieved from http://www.nhlbi.nih.gov/meetings/workshops/Sickle_Cell_Disease_Workshop.pdf
Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP (1994) Mortality of sickle cell disease – life expectancy and risk factors for early death. N Engl J Med 330:1639–1644
Caboot JB, Allen JL (2008) Pulmonary complications of sickle cell disease in children. Curr Opin Pediatr 20:279–287
Field JJ, Glassberg J, Gilmore A et al (2008) Longitudinal analysis of pulmonary function in adults with sickle cell disease. Am J Hematol 83:574–576
Shirlo NR, Lands LC (2011) Asthma and sickle cell chronic lung disease: a dynamic relationship. Peadiatr Respir Review 12:78–82
Young RC, Castro O, Baxter R et al (1981) The lung in sickle cell disease: a clinical overview of common vascular, infectious, and other problems. J National Med Assoc 73(1):19–26
Siddiqui AK, Ahmed S (2003) Pulmonary manifestations of sickle cell disease. Postgrad Med J 79:384–390
Vij R, Machado RF (2010) Pulmonary complications of hemoglobinopathies. Chest 138(4):973–983
Young RC, Wright P, Banks DD (1976) Lung function abnormalities occurring in sickle cell hemoglobinopathies – a preliminary report. J National Med Assoc 68(3):201–205
Pianosi P, D’Souza SJ, Charge TD, Esseltine DE, Coates A (1993) Pulmonary function abnormalities in childhood sickle cell disease. J Pediatr 122:366–371
Miller GJ, Serjeant GR (1971) An assessment of lung volumes and gas transfer in sickle-cell anaemia. Thorax 26:309–315
Miller GJ, Serjeant GR, Saunders MJ, Richardson C, Gilson RJC (1978) Interpretation of lung function tests in the sickle-cell haemoglobinopathies. Thorax 33:85–88
Sylvester KP, Patey RA, Milligan P et al (2004) Pulmonary function abnormalities in children with sickle cell disease. Thorax 59:67–70
Femi-Pearse D, Gazioglu KM, Yu PN (1970) Pulmonary function studies in sickle cell disease. J Appl Physiol 28:574–577
American Thoracic Society (1991) Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 144:1202–1218
American Thoracic Society (1991) Standardization of spirometry: 1994 update. Am Rev Respir Dis 144:1202–1218
Boyd JH, DeBaun MR, Morgan WJ, Mao J, Strunk RC (2009) Lower airway obstruction is associated with increased morbidity in children with sickle cell disease. Pediatr Pulmonol 44(3):290–300
Zapletal A, Samanek M, Paul T (1987) Lung function in children and adolescents: methods, reference values. Prog Respir Res 22:114–218
Vichinsky EP, Styles LA, Colangelo LH et al (1997) The Cooperative Study of Sickle Cell Disease. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood 89:1787–1792
World Health Organization (2013) Growth reference 5-19 years. Retrieved from http://www.who.int/growthref/who2007_height_for_age/en/index.html
Sylvester KP, Patey RA, Milligan P et al (2006) Impact of acute chest syndrome on lung function of children with sickle cell disease. J Pediatr 149:17–22
Bryant R (2005) Asthma in the pediatric sickle cell patient with acute chest syndrome. J Pediatr Health Care 19:157–162
Santoli F, Zerah F, Vasile N et al (1998) Pulmonary function in sickle cell disease with or without acute chest syndrome. Eur Respir J 12:1124–1129
Knight-Madden JM, Forrester TS, Lewis NA, Greenough A (2010) The impact of recurrent acute chest syndrome on the lung function of young adults with sickle cell disease. Lung 188:499–504
Field JJ, Stocks J, Kirkham FJ et al (2011) Airway hyperresponsiveness in children with Sickle cell anemia. Chest 139(3):563–568
Sen N, Kozanoglu I, Karatasli M et al (2009) Pulmonary function and airway hyperresponsiveness in adults with sickle cell disease. Lung 187:195–200
Newaskar M, Hardy KA, Morris CR (2011) Asthma in sickle cell disease. Scientific World J 11:1138–1152
Knight-Madden JM, Forrester TS, Lewis NA, Greenough A (2005) Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax 60:206–210
Sylvester KP, Patey RA, Broughton S et al (2007) Temporal relationship of asthma to acute chest syndrome in sickle cell disease. Pediatr Pulmonol 42:103–106
Field JJ, DeBaun MR (2009) Asthma and sickle cell disease: two distinct diseases or part of the same process. Hematology Am Soc Hematol Educ Program 1:45–53
Morris C (2009) Asthma management: reinventing the wheel in sickle cell disease. Am J Hematol 84:234–241
Schroeder SA, Nepo AG (2008) Treatment of asthma in children with sickle cell disease can prevent recurrences of acute chest syndrome. Am J Respir Crit Care Med 177:A262
Intzes S, Kalpatthi RV, Short R, Imran H (2013) Pulmonary function abnormalities and asthma are prevalent in children with sickle cell disease and are associated with acute chest syndrome. Pediatr Hematol Oncol 27:1–7
Rhodes M, Akohoue S, Shankar S et al (2009) Growth patterns in children with sickle cell anemia during puberty. Pediatr Blood Cancer 53(4):635–641
Singhal A, Thomas P, Cook R, Wierenga K, Serjeant G (1994) Delayed adolescent growth in homozygous sickle cell disease. Arch Dis Childhood 71:404–408
Phebus CK, Gloninger MF, Maciak BJ (1984) Growth patterns by age and sex in children with sickle cell disease. J Pediatr 105(1):28–33
Koumbourlis AC, Lee DJ, Lee A (2007) Longitudinal changes in lung function and somatic growth in children with sickle cell disease. Pediatr Pulmonol 42:483–488
McCormack MK, Dicker L, Katz SH et al (1976) Growth patterns of children with sickle cell disease. Human Biol 48(3):429–437
Koumbourlis AC, Hurlet-Jensen A, Bye MR (1997) Lung function in infants with sickle cell disease. Pediatr Pulmonol 24:277–281
Koumbourlis AC, Zar H, Hurlet-Jensen A, Goldberg M (2001) Prevalence and reversibility of lower airway obstruction in children with sickle cell disease. J Pediatr 138:188–192
Tassel C, Arnaud C, Kulpa M et al (2011) Leukocytosis is a risk factor for lung deterioration in children with sickle cell disease. Respir Med 105(5):788–795